Shin Nippon Biomedical Laboratories Eulerpool Uudised

Shin Nippon Biomedical Laboratories Eulerpool News

Shin Nippon Biomedical Laboratories aktsia uudised

Shin Nippon Biomedical Laboratories jälgivad paljud ajakirjanikud ja investorid üle kogu maailma. Kõige värskemad Shin Nippon Biomedical Laboratories uudised paneme siia kokku.

• 13. juuni ·

  Yahoo
  Satsuma Pharmaceuticals and SNBL Announce Five Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society's 66th Annual Scientific Meeting
• 17. juuli ·

  SeekingAlpha
  Leaven Partners Second Quarter 2023 Letter To Partners
• 15. juuni ·

  Yahoo
  Satsuma Pharmaceuticals and SNBL Announce Three Abstracts on STS101 for the Acute Treatment of Migraine to be Presented at the American Headache Society’s 65th Annual Scientific Meeting
• 18. mai ·

  Yahoo
  Satsuma Pharmaceuticals Announces FDA Acceptance of 505(b)(2) NDA for STS101, a Novel and Investigational Dihydroergotamine (DHE) Nasal Powder Product for the Acute Treatment of Migraine
• 28. juuli ·

  CNBC
  Stocks making the biggest moves midday: Bausch Health, Meta, Comcast, Qualcomm and more
• 28. juuli ·

  CNBC
  Comcast earnings beat Wall Street's estimates, reports flat broadband subscribers
• 28. juuli ·

  CNBC
  Stocks making the biggest moves in the premarket: Stanley Black & Decker, Southwest Airlines, Harley-Davidson and more
• 28. juuli ·

  CNBC
  Comcast fails to add broadband subscribers for first time ever as economy slows
• 26. juuli ·

  CNBC
  WWE at crossroads as Vince McMahon's retirement and scandals heighten sale speculation
• 25. juuli ·

  CNBC
  Sesame Solar is selling mobile disaster relief units powered entirely by clean energy